Free Trial

Telesis Bio (TBIO) Competitors

Telesis Bio logo
$0.20 +0.18 (+1,600.87%)
As of 11:04 AM Eastern

TBIO vs. SMIT, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, and KEYS

Should you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Schmitt Industries (SMIT), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), and Keysight Technologies (KEYS). These companies are all part of the "measuring and control equipment" industry.

Telesis Bio vs.

Telesis Bio (NASDAQ:TBIO) and Schmitt Industries (NASDAQ:SMIT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, community ranking, media sentiment and institutional ownership.

In the previous week, Telesis Bio had 1 more articles in the media than Schmitt Industries. MarketBeat recorded 1 mentions for Telesis Bio and 0 mentions for Schmitt Industries. Telesis Bio's average media sentiment score of 0.00 equaled Schmitt Industries'average media sentiment score.

Company Overall Sentiment
Telesis Bio Neutral
Schmitt Industries Neutral

Schmitt Industries has lower revenue, but higher earnings than Telesis Bio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Telesis Bio$225.09M0.00-$47.72M-$28.20-0.01
Schmitt Industries$9.89M0.01-$3.28MN/AN/A

Schmitt Industries has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company Net Margins Return on Equity Return on Assets
Telesis Bio-336.59% N/A -61.89%
Schmitt Industries N/A N/A N/A

Telesis Bio has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500. Comparatively, Schmitt Industries has a beta of -0.31, meaning that its stock price is 131% less volatile than the S&P 500.

Schmitt Industries received 85 more outperform votes than Telesis Bio when rated by MarketBeat users. Likewise, 55.29% of users gave Schmitt Industries an outperform vote while only 52.94% of users gave Telesis Bio an outperform vote.

CompanyUnderperformOutperform
Telesis BioOutperform Votes
9
52.94%
Underperform Votes
8
47.06%
Schmitt IndustriesOutperform Votes
94
55.29%
Underperform Votes
76
44.71%

37.6% of Telesis Bio shares are owned by institutional investors. 24.5% of Telesis Bio shares are owned by insiders. Comparatively, 17.1% of Schmitt Industries shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Schmitt Industries beats Telesis Bio on 6 of the 11 factors compared between the two stocks.

Get Telesis Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TBIO vs. The Competition

MetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$352,000.00$4.40B$5.37B$8.49B
Dividend YieldN/A0.59%5.28%4.18%
P/E Ratio-0.0127.1726.9219.84
Price / Sales0.003.87398.39139.60
Price / CashN/A36.1638.2534.64
Price / Book1.401.636.774.54
Net Income-$47.72M-$84.30M$3.22B$247.97M
7 Day PerformanceN/A2.81%1.76%1.78%
1 Month Performance-57.62%2.04%7.55%8.82%
1 Year Performance-94.52%-22.08%20.38%9.56%

Telesis Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TBIO
Telesis Bio
N/A$0.20
+1,600.9%
N/A-99.7%$352,000.00$225.09M-0.01200News Coverage
Upcoming Earnings
High Trading Volume
SMIT
Schmitt Industries
N/A$0.02
flat
N/AN/A$72,000.00$9.89M0.00160
SPEC
Spectaire
N/A$0.00
flat
N/A-99.3%$39,000.00N/A0.008
THMO
ThermoGenesis
N/AN/AN/AN/A$1,000.00$9.61M0.0040
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37M0.0090
OLITW
OmniLit Acquisition
N/A$0.04
-10.9%
N/A-52.9%$0.00N/A0.003
PRENW
Prenetics Global
N/A$0.01
+10.0%
N/A+48.0%$0.00$30.62M0.001Short Interest ↓
Gap Up
QSIAW
Quantum-Si
N/A$0.42
-8.9%
N/A+426.6%$0.00$3.06M0.00150Short Interest ↑
SMAPW
SportsMap Tech Acquisition
N/A$0.05
+11.1%
N/A+143.2%$0.00N/A0.00N/AGap Up
TT
Trane Technologies
4.4347 of 5 stars
$431.02
+0.4%
$425.47
-1.3%
+29.1%$96.13B$20.31B38.3139,000Positive News
Short Interest ↓
Analyst Revision
KEYS
Keysight Technologies
4.2222 of 5 stars
$162.76
-1.6%
$181.33
+11.4%
+12.6%$28.13B$5.02B46.5015,000Positive News

Related Companies and Tools


This page (NASDAQ:TBIO) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners